Evaluation of 2 diuretic 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography imaging protocols for intrapelvic cancer
- 1 October 2019
- journal article
- research article
- Published by Edizioni Minerva Medica in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Vol. 63 (3), 284-291
- https://doi.org/10.23736/S1824-4785.17.02912-0
Abstract
BACKGROUND: F-18-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) plays an important part in the oncological evaluation of the abdomen and pelvis, but the interpretation and quantification is often hampered by intense physiological urinary activity. We evaluate 2 different diuretic imaging protocols by comparing intensity of urinary activity and we look at the impact of multiple vanables on the final urinary activity. METHODS: Comparative analysis of 102 patients (median age: 64) having intrapelvic carcinoma. After full body acquisition, 58 patients were administered 20 mg of furosemide 90 min post injection of FDG (P90). For 44 patients, 20 mg of furosemide was administered 30 min post injection of FDG (P30). Comparisons between groups were performed using the Mann-Whitney Test and chi(2). The BMI, creatinine, clearance, age, injected activity, diuretic protocol, gender and glycemia were evaluated with multivariate analysis for their impact on the final urinary activity. RESULTS: Concerning the comparison of the urinary activity we observe a significant difference (P=0.0029) between P90 and P30 for the SUVmax (median 4.3 [range 1.6: 17.7] vs. 6.0 [range 2.9: 15.1]), and for the SUVmax (P= 240 MBq or HMI of >= 25 and a glycemia >120 mg/dL, a significant amount of residual urinary activity remains for both protocols.Keywords
This publication has 15 references indexed in Scilit:
- Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes MellitusMayo Clinic Proceedings, 2011
- FDG-PET/CT for the Preoperative Lymph Node Staging of Invasive Bladder CancerEuropean Urology, 2010
- The effect of furosemide dose timing on bladder activity in oncology imaging with 18F-fluorodeoxyglucose PET/CTNuclear Medicine Communications, 2010
- Forced diuresis and dual-phase 18F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancersIndian Journal of Radiology and Imaging, 2010
- Prospective Study of [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Staging of Muscle-Invasive Bladder CarcinomaJournal of Clinical Oncology, 2009
- Suppressing bladder artifacts in bone SPECT of the pelvisAnnals of Nuclear Medicine, 2007
- 18F-FDG PET/CT Delayed Images After Diuretic for Restaging Invasive Bladder CancerJournal of Nuclear Medicine, 2007
- FDG-PET for preoperative staging of bladder cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Prevention of urinary incontinence in older peopleBJU International, 1998
- Preliminary assessment of fluorine-18 fluorodeoxyglucose positron mission tomography in patients with bladder cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997